Lumenis


Oct 07, 02

08:37 ET Lumenis Ltd. Announces Lawsuit

 
Aug 19, 02

05:32 ET Lumenis ClearLight is First Acne Treatment Device to Receive FDA Clearance

 
05:32 ET Lumenis Ltd. Announces Draw Down on $70 Million Bank Loan

 
Aug 12, 02

05:34 ET Lumenis Announces FDA Clearance For Soft Tissue and Root Canal Treatments With Its OpusDent Erbium Dental Lasers

 
Aug 05, 02

05:38 ET Lumenis Ltd. Announces Results for the Second Quarter

 
Jul 25, 02

05:37 ET Lumenis Ltd. To Hold Conference Call to Review Second Quarter 2002 Results

 
Jul 17, 02

05:35 ET Lumenis Announces Transfer of Manufacturing Operations and New Streamlined Service Depot

 
Jun 13, 02

05:35 ET Lumenis Announces Arbitration Award, Expects to Appeal

 
May 22, 02

07:40 ET Lumenis Receives FDA Marketing Clearance for Treatment of Eczema and Dermatitis with the Multi-Application BClear(TM) Targeted PhotoClearing(TM) System

 
May 13, 02

07:37 ET Lumenis Ltd. Reports First Quarter 2002 Results And Updates Guidance for 2002

 
May 07, 02

07:42 ET Lumenis Ltd. Announces First Quarter 2002 Preliminary Results; Conference Call Scheduled for May 14 at 10:00 a.m. (EDT)

 
Apr 29, 02

07:33 ET Lumenis Announces Status of Acne Treatment 510K Clearance

 
Apr 08, 02

07:32 ET Lumenis Approves Shareholder Rights Plan

 
Apr 04, 02

07:31 ET Lumenis Ends GyneLase(TM)/ELITT(TM) Clinical Trial

 
Mar 27, 02

07:28 ET Lumenis Completes Financing Arrangements to Refinance Its Convertible Notes

 
Feb 28, 02

07:25 ET Lumenis Ltd. Reports Strong 2001 Fourth Quarter and Full Year Results

 
Feb 26, 02

07:15 ET Lumenis Names New Chief Financial Officer

 
Feb 25, 02

07:12 ET Lumenis Announces Refinancing Package

 
07:11 ET Lumenis Responding to SEC Request for Information

 
Feb 19, 02

07:07 ET Lumenis to Introduce BClear, an Innovative Technology for the Treatment Of Psoriasis and Vitiligo, at American Academy of Dermatology

 
Jan 29, 02

07:05 ET Lumenis Announces Record Q4 Revenues

 
Jan 14, 02

07:02 ET Lumenis Signs Additional Distribution Agreement with Boston Scientific

 
Jan 11, 02

06:59 ET Lumenis Establishes European Headquarters in Amsterdam, The Netherlands and Opens Branch in Schaffhausen, Switzerland

 


Issuers of news releases and not PR Newswire are solely responsible for the accuracy of the content.
Terms and conditions, including restrictions on redistribution, apply.
Copyright © 1996-2005 PR Newswire Association LLC. ALL Rights Reserved.
A United Business Media company.